Versantis is a pharmaceutical company developing an innovative drug capture platform to treat life-threatening intoxications. This liposomal system will lead to disruptive drugs in a broad range of indications of high unmet need. Built on a de-risked lead candidate with an orphan status (VS-01) , a lean development and regulatory path, and a qualified management team, Versantis will commercialize in 5 years the first drug to save patients with acute liver disease whose mortality rate is >50%.

2016 Boston Diamond Entrant
Sub industry